Assignee
BRIDGE PHARMA INC
US·30 granted patents·12 pending applications·449 citations·filing 1997–2025
Top patents by PatentIndex Score
42 records- 0194US7718674B2Methods of relieving neuropathic pain with the S-isomer of 2-{2[N-(2-indanyl)-N-phenylamino]ethyl}piperidineBRIDGE PHARMA INC·Filed 2005·Granted May 18, 2010·31 cites·16 claims
- 0293US8557846B1Medicinal treatment of dermal diseases in dogsBRIDGE PHARMA INC·Filed 2013·Granted Oct 15, 2013·17 cites·16 claims
- 0392US9345697B2Methods of treatment of non-histaminic pruritusBRIDGE PHARMA INC·Filed 2015·Granted May 24, 2016·9 cites·10 claims
- 0491US7557128B2Optically active isomers of ketotifen and therapeutically active metabolites thereofBRIDGE PHARMA INC·Filed 2007·Granted Jul 7, 2009·21 cites·12 claims
- 0590US7226934B1Optically active isomers of ketotifen and therapeutically active metabolites thereofBRIDGE PHARMA INC·Filed 2000·Granted Jun 5, 2007·41 cites·13 claims
- 0689US7723392B2Use of RR/SR-ractopamineBRIDGE PHARMA INC·Filed 2008·Granted May 25, 2010·18 cites·22 claims
- 0789US6974820B2Methods for treating urinary incontinence and other disorders using trospiumBRIDGE PHARMA INC·Filed 2003·Granted Dec 13, 2005·28 cites·28 claims
- 0887US9138431B2Methods of treatment of histamine H-4 receptor-related pruritusBRIDGE PHARMA INC·Filed 2013·Granted Sep 22, 2015·10 cites·6 claims
- 0987US8969385B2Ocular formulations of norketotifenBRIDGE PHARMA INC·Filed 2014·Granted Mar 3, 2015·4 cites·14 claims
- 1086US9333199B2Methods of treatment of histamine H-4 receptor-related pruritus associated with nerve disordersBRIDGE PHARMA INC·Filed 2015·Granted May 10, 2016·6 cites·3 claims
- 1186US7985775B2Methods of accelerating muscle growth, decreasing fat deposits and improving feed efficiency in livestock animalsBRIDGE PHARMA INC·Filed 2007·Granted Jul 26, 2011·6 cites·21 claims
- 1284US6207684B1Compounds with combined antihistaminic and mast cell stabilizing activities, intended for ophthalmic useBRIDGE PHARMA INC·Filed 1998·Granted Mar 27, 2001·72 cites·7 claims
- 1383US6432446B2Non-arrhythmogenic metabolite of oxybutyninBRIDGE PHARMA INC·Filed 2001·Granted Aug 13, 2002·20 cites·7 claims
- 1482US6413987B1Dermal anesthetic agentsBRIDGE PHARMA INC·Filed 2000·Granted Jul 2, 2002·20 cites·18 claims
- 1581US7390816B2Methods for treating urinary incontinence in patients suffering from memory disordersBRIDGE PHARMA INC·Filed 2006·Granted Jun 24, 2008·5 cites·19 claims
- 1677US6310103B1S(−)-tolterodine in the treatment of urinary and gastrointestinal disordersBRIDGE PHARMA INC·Filed 1997·Granted Oct 30, 2001·17 cites·12 claims
- 1776US9808419B2Medicinal treatment of dermal infectious disorders with norketotifenBRIDGE PHARMA INC·Filed 2016·Granted Nov 7, 2017·1 cites·9 claims
- 1875US6123961ATreating urinary incontinence with (R)-desethyloxybutynin and (R)-oxybutyninBRIDGE PHARMA INC·Filed 1997·Granted Sep 26, 2000·44 cites·12 claims
- 1974US9694003B2Formulations and methods for treating high intraocular pressureBRIDGE PHARMA INC·Filed 2016·Granted Jul 4, 2017·1 cites·13 claims
- 2068US7141696B2Smooth muscle spasmolytic agentsBRIDGE PHARMA INC·Filed 2004·Granted Nov 28, 2006·4 cites·17 claims
- 2167US6110974AMethods of accelerating muscle growth and improving feed efficiency in animals by using optically pure eutomers of adrenergic beta-2 receptor agonists, and food supplements containing the sameBRIDGE PHARMA INC·Filed 1998·Granted Aug 29, 2000·31 cites·6 claims
- 2265US7872025B2Optically active isomers of ketotifen and therapeutically active metabolites thereofBRIDGE PHARMA INC·Filed 2009·Granted Jan 18, 2011·0 cites·13 claims
- 2364US6207683B1Benzocycloheptathiophene compoundsBRIDGE PHARMA INC·Filed 1998·Granted Mar 27, 2001·21 cites·20 claims
- 2461US8445542B2Methods of accelerating muscle growth, decreasing fat deposits and improving feed efficiency in livestock animalsBRIDGE PHARMA INC·Filed 2012·Granted May 21, 2013·0 cites·19 claims
- 2561US2007282010A1Methods of Accelerating Muscle Growth, Decreasing Fat Deposits and Improving Feed Efficiency in Livestock AnimalsBRIDGE PHARMA INC·Filed 2007·Application pending·0 cites
- 2660US2015272941A1Medicinal treatment of chronic pulmonary inflammatory diseases with norketotifenBRIDGE PHARMA INC·Filed 2013·Application pending·0 cites
- 2759US11197851B2Methods of treatment of asthma and COPDBRIDGE PHARMA INC·Filed 2021·Granted Dec 14, 2021·0 cites·10 claims
- 2856US10959992B2Methods of treatment of asthma and COPDBRIDGE PHARMA INC·Filed 2020·Granted Mar 30, 2021·0 cites·12 claims
- 2955US8383685B2Use of RR/SR-ractopamineBRIDGE PHARMA INC·Filed 2011·Granted Feb 26, 2013·0 cites·3 claims
- 3055US2009137628A1Formulations of Indanylamines and the Use Thereof as Local Anesthetics and as Medication for Chronic PainBRIDGE PHARMA INC·Filed 2006·Application pending·0 cites
- 3152US6207852B1Smooth muscle spasmolytic agents, compositions and methods of use thereofBRIDGE PHARMA INC·Filed 1997·Granted Mar 27, 2001·11 cites·26 claims
- 3251US2023000852A1Treatment of Dermal Cytokine Storm SyndromesBRIDGE PHARMA INC·Filed 2022·Application pending·0 cites
- 3350US2018344721A1Medicinal Treatment of Chronic Inflammatory Dermal DisordersBRIDGE PHARMA INC·Filed 2018·Application pending·0 cites
- 3449US6372799B1Non-sedating diphenhydramine metabolitesBRIDGE PHARMA INC·Filed 1999·Granted Apr 16, 2002·11 cites·18 claims
- 3549US2021267960A1Methods of treatment of inflammatory cytokine-related arthritic disordersBRIDGE PHARMA INC·Filed 2021·Application pending·0 cites
- 3648US2014120121A1Medicinal treatment of atopic inflammatory diseasesBRIDGE PHARMA INC·Filed 2013·Application pending·0 cites
- 3747US9439895B2Methods of treating pruritic conditions mediated through non-histaminergic mechanisms in diabetic patientsBRIDGE PHARMA INC·Filed 2016·Granted Sep 13, 2016·0 cites·10 claims
- 3845US2020268734A1Methods of treatment of respiratory disordersBRIDGE PHARMA INC·Filed 2020·Application pending·0 cites
- 3945US2011218218A1Formulations Of Indanylamines And The Use Thereof As Local Anesthetics And As Medication For Chronic PainBRIDGE PHARMA INC·Filed 2011·Application pending·0 cites
- 4044US2006079558A1R-isomer of 2-{2[N-(2-indanyl)-N-phenylamino]ethyl}piperidine and other dermal anestheticsBRIDGE PHARMA INC·Filed 2005·Application pending·0 cites
- 4142US2025186421A1Methods of treating inflammatory and/or allergic disorders with norketotifenBRIDGE PHARMA INC·Filed 2025·Application pending·0 cites
- 4242US2010179114A1S-Isomer of 2- piperidine and Other Dermal Anesthetic AgentsBRIDGE PHARMA INC·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when BRIDGE PHARMA INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →